Biotech Values

[poorgradstudent]

As a general rule, the relevant, pre-specified endpoints are the ones that you hear companies talk about before the data are released.

The exploratory ones are the new ones that you hear about for the first time on the day of data release or months after the initial data are released.

At least that's the way I see it. If it was so important to a biotech's trial, they'd be talking about it before the data release.